Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455


Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?

Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J.

Circulation. 2013 Jan 29;127(4):452-62. doi: 10.1161/CIRCULATIONAHA.112.100123. Epub 2012 Dec 27.


Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.


Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.

Dardas T, Mokadam NA, Pagani F, Aaronson K, Levy WC.

J Am Coll Cardiol. 2012 Jul 3;60(1):36-43. doi: 10.1016/j.jacc.2012.02.031. Epub 2012 Apr 25.


Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.


Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.

Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH.

Ann Thorac Surg. 2013 Mar;95(3):870-5. doi: 10.1016/j.athoracsur.2012.10.080. Epub 2012 Dec 4.


Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.

Trivedi JR, Cheng A, Singh R, Williams ML, Slaughter MS.

Ann Thorac Surg. 2014 Sep;98(3):830-4. doi: 10.1016/j.athoracsur.2014.05.019. Epub 2014 Jul 31.


Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.

Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J.

J Heart Lung Transplant. 2011 Aug;30(8):854-61. doi: 10.1016/j.healun.2011.03.019. Epub 2011 May 14.


Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts.

Singh TP, Almond CS, Taylor DO, Graham DA.

Circ Heart Fail. 2012 Mar 1;5(2):249-58. doi: 10.1161/CIRCHEARTFAILURE.111.964247. Epub 2012 Jan 13.


Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.

Jeewa A, Manlhiot C, Kantor PF, Mital S, McCrindle BW, Dipchand AI.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):462-8. doi: 10.1016/j.jtcvs.2013.09.018. Epub 2013 Nov 1.


Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.

Taghavi S, Jayarajan SN, Komaroff E, Mangi AA.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1966-71, 1971.e1. doi: 10.1016/j.jtcvs.2014.02.001. Epub 2014 Feb 12.


Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database.

Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH.

Ann Thorac Surg. 2014 Apr;97(4):1364-71; discussion 1371-2. doi: 10.1016/j.athoracsur.2013.10.077. Epub 2014 Jan 11.


The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.

Patlolla V, Patten RD, Denofrio D, Konstam MA, Krishnamani R.

J Am Coll Cardiol. 2009 Jan 20;53(3):264-71. doi: 10.1016/j.jacc.2008.08.070.


Pediatric heart transplant waiting list mortality in the era of ventricular assist devices.

Zafar F, Castleberry C, Khan MS, Mehta V, Bryant R 3rd, Lorts A, Wilmot I, Jefferies JL, Chin C, Morales DL.

J Heart Lung Transplant. 2015 Jan;34(1):82-8. doi: 10.1016/j.healun.2014.09.018. Epub 2014 Oct 14.


Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?

Allen JG, Kilic A, Weiss ES, Arnaoutakis GJ, George TJ, Shah AS, Conte JV.

Ann Thorac Surg. 2012 Dec;94(6):2017-24. doi: 10.1016/j.athoracsur.2012.06.009. Epub 2012 Aug 2.


Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.


Stable patients on left ventricular assist device support have a disproportionate advantage: time to re-evaluate the current UNOS policy.

Moazami N, Sun B, Feldman D.

J Heart Lung Transplant. 2011 Sep;30(9):971-4. doi: 10.1016/j.healun.2011.05.004. Epub 2011 Jun 14.


The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.

Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS.

ASAIO J. 2014 May-Jun;60(3):294-9. doi: 10.1097/MAT.0000000000000065.


Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.

Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS.

J Heart Lung Transplant. 2013 Nov;32(11):1059-64. doi: 10.1016/j.healun.2013.06.024. Epub 2013 Aug 6.

Items per page

Supplemental Content

Write to the Help Desk